Skip to main content
Log in

On the Fleming—Harrington test for late effects in prevention randomized controlled trials

  • Published:
Journal of Statistical Theory and Practice Aims and scope Submit manuscript

Abstract

Weighted logrank tests are the usual tool for detecting late effects in clinical trials. Weights determine the alternative hypotheses against which the tests are optimal. Choosing a specific weight is thus a crucial issue in practice. One common weight was introduced in 1982 by Harrington and Fleming. The corresponding test is implemented in standard statistical softwares packages. However, using this test in randomized controlled clinical trials raises two major and still unsolved difficulties. First, the weight depends on a parameter q that has to be set before collecting the data. Second, the necessary sample size depends on this q. This article addresses these difficulties. We provide the explicit form of the alternative hypothesis under which the Fleming–Harrington test for late effects is optimal in terms of Pitman’s asymptotic relative efficiency. Using simulations, we investigate various aspects of the Fleming–Harrington test for late effects, such as power properties and sensitivity to the value of q. We also investigate the relation between q and the necessary sample size for the Fleming–Harrington test. Based on these results, we propose q = 3 as a general choice for testing late effects. We illustrate our methodology on a data set arising from a prevention trial in the field of dementia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andrieu, S., N. Coley, S. Lovestone, P. S. Aisen, and B. Vellas. 2015. Prevention of sporadic Alzheimer’s disease: Lessons learned from clinical trials and future directions. Lancet Neurology 14 (9):926–44.

    Google Scholar 

  • Andrieu, S., S. Gillette, K. Amouyal, F. Nourhashemi, E. Reynish, P. J. Ousset, J. L. Albarede, B. Vellas, and H. Grandjean. 2003. Association of Alzheimer’s disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. Journals of Gerontology Series A, Biological Sciences and Medical Sciences 58 (4):372–77.

    Google Scholar 

  • Andrieu, S., P. J. Ousset, N. Coley, M. Ouzid, H. Mathiex-Fortunet, and B. Vellas. 2008. GuidAge study: A 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer’s disease in elderly subjects with memory complaints. I. Rationale, design and baseline data. Current Alzheimer Research 5(4):406–15.

    Google Scholar 

  • Billingsley, P. 1999. Convergence of probability measures, 2nd ed. Wiley Series in Probability and Statistics: Probability and Statistics. New York, NY: John Wiley & Sons.

    MATH  Google Scholar 

  • Breslow, N. E., L. Edler, and J. Berger. 1984. A two-sample censored-data rank test for acceleration. Biometrics 40(4):1049–62.

    MATH  Google Scholar 

  • Brookmeyer, R. 2007. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia 3(3):186–91.

    MathSciNet  Google Scholar 

  • Brookmeyer, R., S. Gray, and C. Kawas. 1998. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health 88 (9):1337–42.

    Google Scholar 

  • Buyske, S., R. Fagerstrom, and Z. Ying. 2000. A class of weighted log-rank tests for survival data when the event is rare. Journal of the American Statistical Association 95 (449):249–58.

    MathSciNet  MATH  Google Scholar 

  • Cox, D. R. 1972. Regression models and life-tables. Journal of the Royal Statistical Society Series B 34:187–220.

    MathSciNet  MATH  Google Scholar 

  • DeKosky, S. T. 2008. Ginkgo biloba for prevention of dementia: a randomized controlled trial. Journal of the American Medical Association 300(19):2253–62.

    Google Scholar 

  • Eng, K. H., and M. R. Kosorok. 2005. A sample size formula for the supremum log-rank statistic. Biometrics 61(1):86–91.

    MathSciNet  MATH  Google Scholar 

  • Fleming, T. R., and D. P. Harrington. 1991. Counting processes and survival analysis. Wiley Series in Probability and Mathematical Statistics: Applied Probability and Statistics. New York, NY: John Wiley & Sons.

    MATH  Google Scholar 

  • Fleming, T. R., D. P. Harrington, and M. O’Sullivan. 1987. Supremum versions of the log-rank and generalized Wilcoxon statistics. Journal of the American Statistical Association 82 (397):312–20.

    MathSciNet  MATH  Google Scholar 

  • Garès, V. 2014. Améliorer la performance des analyses de survie dans le cadre des essais de prévention et application à la maladie dAlzheimer. PhD thesis, Université de Toulouse, Toulouse, France. https://doi.org/thesesups.ups-tlse.fr/2393/1/2014TOU30048.pdf

  • Garès, V., S. Andrieu, J.-F. Dupuy, and N. Savy. 2013. Comparison of constant piecewise weighted test and Fleming Harrington’s test — Application in clinical trials. Electronic Journal of Statistics 8 (1):841–860.

    MATH  Google Scholar 

  • Garès, V., S. Andrieu, J.-F. Dupuy, and N. Savy. 2015. An omnibus test for several hazard alternatives in prevention randomized controlled clinical trials. Statistics in Medicine 34 (4):541–57.

    MathSciNet  Google Scholar 

  • Gastwirth, J. L. 1985. The use of maximin efficiency robust tests in combining contingency tables and survival analysis. Journal of the American Statistical Association 80 (390):381–84.

    MathSciNet  MATH  Google Scholar 

  • Gehan, E. A. 1965. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203–23.

    MathSciNet  MATH  Google Scholar 

  • Gill, R. 1980. Censoring and stochastic integrals. Mathematical Centre Tracts 124. Amsterdam, The Netherlands: Mathematisch Centrum.

    MATH  Google Scholar 

  • Halperin, M., E. Rogot, J. Gurian, and F. Ederer. 1967. Sample sizes for medical trials with special reference to long-term therapy. Biometrics 21:13–24.

    Google Scholar 

  • Harrington, D. P., and T. R. Fleming. 1982. A class of rank test procedures for censored survival data. Biometrika 69 (3):553–66.

    MathSciNet  MATH  Google Scholar 

  • Jung, S. H. 2008. Sample size calculation for the weighted rank statistics with paired survival data. Statistics in Medicine 27 (17):3350–65.

    MathSciNet  Google Scholar 

  • Kosorok, M. R. 2008. Introduction to empirical processes and semiparametric inference. Springer Series in Statistics. New York, NY: Springer.

    MATH  Google Scholar 

  • Kosorok, M. R., and C. Y. Lin. 1999. The versatility of function-indexed weighted log-rank statistics. Journal of the American Statistical Association 94 (445):320–32.

    MathSciNet  MATH  Google Scholar 

  • Lai, T. L., and Z. Ying. 1991. Rank regression methods for left-truncated and right-censored data. Annals of Statistics 19 (2):531–56.

    MathSciNet  MATH  Google Scholar 

  • Lakatos, E., and K. G. Lan. 1992. A comparison of sample size methods for the logrank statistic. Statistics in Medicine 11:179–91.

    Google Scholar 

  • Lee, J. W. 1996. Some versatile tests based on the simultaneous use of weighted log-rank statistics. Biometrics 52 (2):721–25.

    MathSciNet  MATH  Google Scholar 

  • Lyketsos, C. G. 2007. Naproxen and celecoxib do not prevent Alzheimer’s disease in early results from a randomized controlled trial. Neurology 68 (21):1800–1808.

    Google Scholar 

  • Machin, D., M. J. Campbell, T. S. Beng, and T. S. Huey. 2009. Sample size tables for clinical studies. New York, NY: John Wiley & Sons.

    Google Scholar 

  • Mantel, N., and W. Haenszel. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer 22:719–48.

    Google Scholar 

  • Martinussen, T. and T. H. Scheike. 2006. Dynamic regression models for survival data. Statistics for Biology and Health. New York, NY: Springer.

    MATH  Google Scholar 

  • Pecková, M. and T. R. Fleming. 2003. Adaptive test for testing the difference in survival distributions. Lifetime Data Analysis 9 (3):223–38.

    MathSciNet  MATH  Google Scholar 

  • Peto, R., and J. Peto. 1972. Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society Series A 135:185–206.

    MATH  Google Scholar 

  • Prentice, R. L. 1978. Linear rank tests with right censored data. Biometrika 65 (1):167–79.

    MathSciNet  MATH  Google Scholar 

  • Scherrer, B., S. Andrieu, P. J. Ousset, G. Berrut, J. F. Dartigues, B. Dubois, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet, B. Vellas, and the GuidAge Study Group. 2015. Analysing time to event data in dementia prevention trials: The example of the GuidAge study of EGb761. Journal of Nutrition Health and Aging 19 (10):1009–11.

    Google Scholar 

  • Schork, M. A., and R. D. Remington. 1967. The determination of sample size in treatment-control comparisons for chronic disease studies in which noncompliance or nonadherence is a problem. Journal of Chronic Diseases 20:233–39.

    Google Scholar 

  • Self, S. G. 1991. An adaptive weighted log-rank test with application to cancer prevention and screening trials. Biometrics 47 (3):975–86.

    Google Scholar 

  • Shumaker, S. A. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 289 (20):2651–62.

    Google Scholar 

  • Shumaker, S. A. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. Journal of the American Medical Association 291 (24):2947–58.

    Google Scholar 

  • Tarone, R. E., and J. Ware. 1977. On distribution-free tests for equality of survival distributions. Biometrika 64 (1):156–60.

    MathSciNet  MATH  Google Scholar 

  • Van der Vaart, A. W. 1998. Asymptotic statistics, Vol. 3 of Cambridge Series in Statistical and Probabilistic Mathematics. Cambridge, UK: Cambridge University Press.

    Google Scholar 

  • Vellas, B., N. Coley, P. J. Ousset, G. Berrut, J. F. Dartigues, B. Dubois, H. Grandjean, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet, and S. Andrieu for the GuidAge Study Group. 2012. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurology 11:851–59.

    Google Scholar 

  • Wallenstein, S., and A. Berger. 1997. Weighted logrank tests to detect a transient improvement in survivorship. Biometrics 53 (2):736–44.

    MATH  Google Scholar 

  • Wimo, A., and M. Prince. 2010. World Alzheimer report 2010: The global economic impact of dementia. London, UK: Alzheimer’s Disease International.

    Google Scholar 

  • Wu, L., and P. B. Gilbert. 2002. Flexible weighted log-rank tests optimal for detecting early and/or late survival differences. Biometrics 58 (4):997–1004.

    MathSciNet  MATH  Google Scholar 

  • Yang, S., and R. Prentice. 2010. Improved logrank-type tests for survival data using adaptive weights. Biometrics 66 (1):30–38.

    MathSciNet  MATH  Google Scholar 

  • Zucker, D. M. 1992. The efficiency of a weighted log-rank test under a percent error misspecification model for the log hazard ratio. Biometrics 48 (3):893–899.

    MathSciNet  MATH  Google Scholar 

  • Zucker, D. M., and E. Lakatos. 1990. Weighted log rank type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment. Biometrika 77 (4):853–64.

    MathSciNet  MATH  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valérie Garès.

Additional information

Supplemental data for this article can be accessed on the publisher’s website.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garès, V., Andrieu, S., Dupuy, JF. et al. On the Fleming—Harrington test for late effects in prevention randomized controlled trials. J Stat Theory Pract 11, 418–435 (2017). https://doi.org/10.1080/15598608.2017.1295889

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1080/15598608.2017.1295889

Keywords

AMS Subject Classification

Navigation